Bottom line
Is POVYX a good fund? The bottom line
POVYX is the CLASS Y share class of Putnam International Equity Fund /ma/, a managed international stock mutual fund from Franklin Templeton.
Its expense ratio is 0.79% — about $79 a year on every $10,000 invested, cheaper than 64% of international stock funds we track.
It returned +37.5% over one year, +9.6% a year over five years, +8.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $1.0 billion in net assets and 251 holdings, its largest position is ASML Holding NV (3.9%) and the top 10 make up 29.8% of the portfolio.
What stands out
- 5-year return beat 79% of category peers
- Broadly diversified (251 holdings)
- No front-end sales load
Updated Nov 19, 2026
What POVYX invests in
The fund seeks capital appreciation.
The fund invests mainly in common stocks (growth or value stocks or both) of large and midsize companies outside the United States that the Investment Manager, as defined below, believes have favorable investment potential. For example, the fund may purchase stocks of companies with stock prices that reflect a value lower than that which the Investment Manager places on the company. Under normal circumstances, the fund invests at least 80% of its net assets in equity investments. This policy may be changed only after 60 days notice to shareholders. The Investment Manager may consider, among other factors, a companys valuation, financial strength, growth potential, competitive position in its industry, projected future earnings, cash flows and dividends when deciding whether to buy or sell investments. The Investment Manager may also consider other factors that the Investment Manager…
From the fund's prospectus (filed Oct 26, 2026).
POVYX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| POVYX | +37.5% | +9.6% | +8.3% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What POVYX costs
On a $10,000 investment, POVYX's 0.79% expense ratio costs about $79 a year. The prospectus estimates $1,174 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
POVYX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | ASML Holding NV | 3.92% |
| 2 | AstraZeneca plc | 3.41% |
| 3 | Mitsubishi UFJ Financial Group, Inc. | 3.03% |
| 4 | Roche Holding AG | 2.96% |
| 5 | Safran SA | 2.89% |
| 6 | British American Tobacco plc | 2.79% |
| 7 | Sumitomo Mitsui Financial Group, Inc. | 2.79% |
| 8 | Iberdrola SA | 2.76% |
| 9 | Banco Santander SA | 2.76% |
| 10 | BHP Group Ltd. | 2.50% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 29.8% of the fund. See all top 25 holdings and asset mix →